/MRMD
MRMD Stock - MariMed Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.11-7.11%
$0.01 (-7.11%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.55
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+1927.0%upside
Target: $2.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MRMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.11 – $0.11
TARGET (TP)$2.25
STOP LOSS$0.10
RISK/REWARD1:194.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.02
52W High$0.23
52W Low$0.07
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $157.96M | $148.60M | $134.01M | $121.46M | $50.90M |
| Gross Profit | $62.87M | $65.92M | $63.96M | $66.26M | $31.32M |
| Gross Margin | 39.8% | 44.4% | 47.7% | 54.6% | 61.5% |
| Operating Income | $2.91M | $15.08M | $20.37M | $26.86M | $14.53M |
| Net Income | $-12,164,000 | $-16,031,000 | $13.47M | $7.22M | $2.14M |
| Net Margin | -7.7% | -10.8% | 10.0% | 5.9% | 4.2% |
| EPS | $-0.03 | $-0.04 | $0.04 | $0.02 | $0.01 |
Company Overview
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MRMDBeat Rate
17%
Last 12 quarters
Avg Surprise
-61.1%
EPS vs Estimate
Beats / Misses
2/5
5 met exactly
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
-100.0%
$-0.00vs$-0.00
Q3 24
-99.5%
$-0.00vs$-0.00
Q4 24
-100.0%
$-0.00vs$-0.00
Q1 25
0.0%
$-0.01vs$-0.01
Q2 25
0.0%
$-0.01vs$-0.01
Q3 25
+67.5%
$-0.00vs$-0.01
Q4 25
0.0%
$-0.01vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Mar 4, 2026 | $-0.01 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.01 | $-0.01 | 0.0% | = MET |
Q3 2025 | Aug 6, 2025 | $-0.01 | $-0.00 | +67.5% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2025 | Mar 5, 2025 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2024 | Nov 6, 2024 | $-0.00 | $-0.00 | -100.0% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $-0.00 | $-0.00 | -99.5% | ✗ MISS |
Q2 2024 | May 8, 2024 | $-0.00 | $-0.00 | -100.0% | ✗ MISS |
Q1 2024 | Mar 6, 2024 | — | $-0.03 | — | — |
Q4 2023 | Nov 8, 2023 | $-0.01 | $-0.01 | -100.0% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 8, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 1, 2023 | $0.01 | $0.01 | +100.0% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $0.01 | $0.01 | 0.0% | = MET |
Q3 2022 | Aug 8, 2022 | — | $0.00 | — | — |
Q2 2022 | May 10, 2022 | $0.01 | $0.01 | 0.0% | = MET |
Q1 2022 | Mar 16, 2022 | $-0.00 | $-0.02 | -500.6% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | — | $0.01 | — | — |
Q3 2021 | Aug 16, 2021 | — | $0.02 | — | — |
Frequently Asked Questions about MRMD
What is MRMD's current stock price?
MariMed Inc. (MRMD) is currently trading at $0.11 per share. The stock has moved -7.11% today.
What is the analyst price target for MRMD?
The average analyst price target for MRMD is $2.25, based on 1 analyst.
What sector is MariMed Inc. in?
MariMed Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is MRMD's market cap?
MariMed Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does MRMD pay dividends?
No, MariMed Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCXXIF
C21 Investments Inc.
$0.32
Mkt Cap: $0.0B
DXBRF
BellRock Brands Inc.
$0.00
Mkt Cap: $0.0B
ELIXF
Elixxer Ltd.
$0.04
Mkt Cap: $0.0B
FLOOF
Flower One Holdings Inc.
$0.00
Mkt Cap: $0.0B
LEEEF
Leef Brands Inc.
$0.18
Mkt Cap: $0.0B
MILFF
1CM Inc.
$0.14
Mkt Cap: $0.0B
SNNVF
Sunniva Inc.
$0.00
Mkt Cap: $0.0B
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
Mkt Cap: $0.0B
TCNAF
TransCanna Holdings Inc.
$0.00
Mkt Cap: $0.0B
VEXTF
Vext Science, Inc.
$0.23
Mkt Cap: $0.1B
Explore stocks similar to MRMD for comparison